Wat is de prijs voor Novan, Inc. (NOVN)

Het prijs van Novan, Inc. (NOVN) is $0.056

Wat is de marktkapitalisatie voor Novan, Inc. (NOVN)

Marktkapitalisatie voorNovan, Inc. (NOVN) is $451.38K

Novan, Inc. (NOVN) Prijsgeschiedenis

Novan, Inc. operates as a pre-commercial pharmaceutical entity specializing in nitric oxide-derived therapies for dermatological and anti-infective conditions. The company boasts a robust clinical-stage pipeline featuring several topical drug candidates. For skin-related ailments, these include SB204, a monotherapy aimed at acne vulgaris; SB206, an antiviral gel targeting viral skin infections; SB208, a broad-spectrum antifungal gel designed to combat various fungal skin and nail infections like athlete's foot; and SB414, a cream-based gel formulated for inflammatory skin diseases. Additionally, Novan is advancing SB207 to treat external genital warts, WH602 (an intravaginal gel) and WH504 (a non-gel formulation) both addressing high-risk human papillomavirus (HPV), and SB019, a candidate for SARS-CoV-2. The firm has cultivated strategic partnerships, holding a licensing agreement with Sato Pharmaceutical Co., Ltd., and engaging in a strategic alliance with Orion Corporation. Founded in 2006, Novan, Inc. maintains its headquarters in Durham, North Carolina.

Jaar	Prestaties
2023	-95.77%
2022	-71.33%
2021	-31.07%
2020	-74.28%
2019	118.01%
2018	-74.35%
2017	-83.34%
2016	0.00%

Jaar

Prestaties

2023

-95.77%

2022

-71.33%

2021

-31.07%

2020

-74.28%

2019

118.01%

2018

-74.35%

2017

-83.34%

2016

0.00%

Bedrijf	Aandelenkoers	Verandering 1jr%	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$517.18	32.51%	US
Argenx SE ARGX.US	$857.76	31.47%	NL
Lonza Group AG LONN.SW	$733.78	7.43%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.07K	-6.40%	KR
UCB S.A. UCB.BR	$259.89	14.81%	BE

Bedrijf

Aandelenkoers

Verandering 1jr%

Land